ArticleRheumatology advances in practice2022

Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study.

György Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.